A practical reference on metabolic research: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2025-12-26. Anything still debated is marked as such rather than presented as settled.
Research has examined whether the peptide affects fat mass independently of growth hormone's other actions. Early animal studies suggested reductions in body fat, but species differences and small sample sizes limit interpretation. Human studies have generally been short and have not consistently shown large effects. Some trials measured body composition, lipid profiles, and safety parameters, but the overall picture is one of suggestive yet inconclusive metabolic activity. Findings vary across study populations and protocols.
A central uncertainty is whether observed metabolic changes translate into meaningful clinical benefits. Study designs vary in dose, duration, and participant characteristics, making comparisons difficult. Independent replication is limited, and the field lacks consensus on optimal endpoints or treatment duration. Ongoing or future studies may clarify mechanism and effect size, but current evidence does not establish a clear therapeutic role. Researchers often call for larger, longer, and better-controlled trials, while questions remain about which patient groups might respond.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic peptide fragment | Not a full hormone |
| Molecular target | Proposed adipose tissue lipolysis | Receptor details uncertain |
| Typical research dose | Not established for clinical use | Doses vary across studies |
| Stability in solution | Limited; store cold | Avoid repeated freeze-thaw |
| Regulatory status | Not approved as a drug | Varies by country |
Other studies confirm a dependence of ESR on age and gender, as seen in the following: ESR reference ranges from a large 1996 study of 3,910 healthy adults (NB. these use 95% confidence intervals rather than the 98% intervals used in the study used to derive the formula above, and because of the skewness of the data, these values appear to be less than expected from the above formula):
== Cis/trans isomers of the peptide group == Significant delocalisation of the lone pair of electrons on the nitrogen atom gives the group a partial double-bond character. The partial double bond renders the amide group planar, occurring in either the cis or trans isomers. In the unfolded state of proteins, the peptide groups are free to isomerize and adopt both isomers; however, in the folded state, only a single isomer is adopted at each position (with rare exceptions). The trans form is preferred overwhelmingly in most peptide bonds (roughly 1000:1 ratio in trans:cis populations). However, X-Pro peptide groups tend to have a roughly 30:1 ratio, presumably because the symmetry between the Cα and Cδ atoms of proline makes the cis and trans isomers nearly equal in energy, as shown in the figure below.
In addition, various side effects, including insomnia, sedation, weight loss, constipation, dry mouth, erectile dysfunction, excessive sweating, and urinary retention, among others, have been found to be around twice as frequent in poor metabolizers relative to extensive metabolizers. The same was true for discontinuation rates (11.2% vs. 6.3%). In terms of dosage adjustment for CYP2D6 poor metabolizers or those taking strong CYP2D6 inhibitors, the Food and Drug Administration (FDA) label says that this may be necessary and provides directions for this, whereas literature reviews state that it is not considered necessary based on clinical trial experience.
Sir Ninian Martin Stephen was selected by Queen Elizabeth II to become the next Governor-General of Australia, to take the place of Sir Zelman Cowen at the latter's retirement in July. Died: Marcel Camus, 69, French film director known for Black Orpheus (Orfeu Negro), winner of the 1959 Palme d'Or and the 1960 Academy Award for Best Foreign Language Film, died following open heart surgery.
Tools such as GPTZero can detect content generated by AI. However, they can also make false accusations (false positives). Digital watermarking is a technique that improves detection accuracy. It works by altering the generated content at the source, in subtle ways which can be detected by corresponding software. In 2023, OpenAI developed a watermarking tool for ChatGPT. However, it was not released, because they worried that users would switch to competitors. They also argued that it would be easy to circumvent, for example by asking another AI to rephrase. In March 2025, China issued requirements for online service providers to label AI content. In May 2025, Google deployed its watermarking tool, SynthID. It marks output from Gemini (text), Imagen (images), and Veo (video). To detect output from these products, one uses Google's "SynthID detector" portal. In 2025, users mistakenly accused gaming companies of using generative AI for the video games Little Droid and Chessplus.
Sources: en.wikipedia.org
== Nazi Resistance == The BRSD positioned itself squarely against National Socialism. It referred to Nazism as "pre-Christian, heathen destructive power' and criticized the ideological glorification of violence by the Nazis. As with other socialist organizations, the Federation was banned once the Nazis seized power, however, various members of the organization formed resistance groups, such as Erich Kürschner in Berlin.
=== Pusha T's feud with Jim Jones === Rapper Jim Jones made headlines in 2023 for questioning Pusha T's placement in a top fifty rappers of all-time list on the RapCaviar podcast. He repeated his stance during an interview on radio show The Breakfast Club. Pusha T's verse on "Chains & Whips", the first song from Let God Sort Em Out teased at a Louis Vuitton fashion show in 2023, was reported as a response to Jones; in the lyrics, Pusha T accused Jones of jealousy and implied that his comments were made to cosy up to Drake, Pusha T's rival who had brought Jones out as a guest at a concert shortly before the RapCaviar interview. Jones reignited the feud after the release of the lead single "Ace Trumpets" in 2025: "I don't believe it, I don't believe them." When asked about the feud in June 2025, Pusha T responded: "I personally never understood what the interviews were about [...] or why my name kept coming up. It's one thing to keep saying I'm not a top fifty MC, but it's another thing for you not to say that you [yourself] are one. No one asked me about a top fifty nothing. After about the third interview, I promise you, I said, 'Man, he must really want me to know what he thinks about me.' And that's how [my] verse came. This is what I really think about him. This is what I really think about him. Every line is my true heart."
Reaction of strontium carbonate with titanium dioxide at high temperature produces the desired strontium titanate plus carbon dioxide. If desired, the strontium titanate product can then be formed into a ceramic-like aggregate via sintering.
(CH2CH2)O + RCOCl + NaI → RC(O)–OCH2CH2–I + NaCl Heating ethylene oxide to 100 °C with carbon dioxide, in a non-polar solvent in the presence of bis-(triphenylphosphine)-nickel(0) results in ethylene carbonate:
Sources: en.wikipedia.org
It is proposed to promote lipolysis in fat tissue, the breakdown of stored fat into fatty acids and glycerol. The detailed receptor and signaling mechanisms are not fully established.
Because it is a fragment rather than full growth hormone, it is generally described as lacking growth-promoting effects. Some studies suggest it may influence fat metabolism without the same systemic growth effects, though evidence is limited.
Human trials have measured body weight, fat mass, lean mass, lipid levels, and adverse events. Most have been small or short-term, so conclusions about long-term outcomes are limited.
Yes, the World Anti-Doping Agency classifies AOD-9604 as a prohibited peptide hormone and related substance. Its use by athletes is banned under the relevant anti-doping code.